ATE508750T1 - Derivate von vitamin d und ihre verwendung in der therapie - Google Patents

Derivate von vitamin d und ihre verwendung in der therapie

Info

Publication number
ATE508750T1
ATE508750T1 AT06845248T AT06845248T ATE508750T1 AT E508750 T1 ATE508750 T1 AT E508750T1 AT 06845248 T AT06845248 T AT 06845248T AT 06845248 T AT06845248 T AT 06845248T AT E508750 T1 ATE508750 T1 AT E508750T1
Authority
AT
Austria
Prior art keywords
vitamin
therapy
derivatives
analogs
relates
Prior art date
Application number
AT06845248T
Other languages
English (en)
Inventor
Laurent Brard
Satyan Kalkunte
Rakesh Singh
Original Assignee
Women And Infants Hospital Of Rhode Island
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Women And Infants Hospital Of Rhode Island filed Critical Women And Infants Hospital Of Rhode Island
Application granted granted Critical
Publication of ATE508750T1 publication Critical patent/ATE508750T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT06845248T 2005-12-12 2006-12-12 Derivate von vitamin d und ihre verwendung in der therapie ATE508750T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74940505P 2005-12-12 2005-12-12
PCT/US2006/047320 WO2007070494A2 (en) 2005-12-12 2006-12-12 Heterocycles and derivatives thereof and methods of manufacture and therapeutic use

Publications (1)

Publication Number Publication Date
ATE508750T1 true ATE508750T1 (de) 2011-05-15

Family

ID=38163466

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06845248T ATE508750T1 (de) 2005-12-12 2006-12-12 Derivate von vitamin d und ihre verwendung in der therapie

Country Status (4)

Country Link
US (1) US9024039B2 (de)
EP (1) EP1968383B1 (de)
AT (1) ATE508750T1 (de)
WO (1) WO2007070494A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8399438B2 (en) * 2004-11-22 2013-03-19 Wisconsin Alumni Research Foundation 2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses
WO2012170513A2 (en) 2011-06-06 2012-12-13 Women & Infants' Hospital Of Rhode Island He4 based therapy for malignant disease

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4366320A (en) * 1980-07-31 1982-12-28 The Upjohn Company 4-Substituted phenyl-1,2,4-triazoline-3,5-diones and their dihydro analogs as analytical reagents
IL67153A (en) * 1981-11-02 1986-12-31 Res Inst Medicine Chem Intermediates in the production of vitamin d analogues and method for their production
EP0078705B1 (de) * 1981-11-02 1988-04-27 Research Institute For Medicine And Chemistry Inc. Verfahren zur Herstellung von 1-hydroxylierten Vitamin D Derivaten
JPS59163364A (ja) 1983-03-08 1984-09-14 Chugai Pharmaceut Co Ltd 6,19−エチレンビタミンd↓3誘導体
US5629008A (en) * 1992-06-02 1997-05-13 C.R. Bard, Inc. Method and device for long-term delivery of drugs
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
AU7497798A (en) * 1997-05-16 1998-12-08 F. Hoffmann-La Roche Ag 3-epi compounds of vitamin d3 and uses thereof
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
WO2004002996A1 (ja) * 2002-06-27 2004-01-08 Chugai Seiyaku Kabushiki Kaisya フェロセン化合物およびその用途
US20050059641A1 (en) * 2003-06-17 2005-03-17 Aphios Corporation Compositions and methods for treating and preventing cancer using analogs of vitamin D
CA2539708A1 (en) 2003-09-24 2005-04-07 Bioxell S.P.A. 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
CN102812356B (zh) * 2009-12-11 2017-08-08 奎斯特诊断投资公司 多重样品中的甾族化合物的质谱法
EP2528443B1 (de) * 2010-01-25 2017-01-11 DH Technologies Development Pte. Ltd. Quantitative analyse von vitamin d3, vitamin d2 und metaboliten davon

Also Published As

Publication number Publication date
US20090221529A1 (en) 2009-09-03
EP1968383B1 (de) 2011-05-11
EP1968383A4 (de) 2010-01-20
WO2007070494A2 (en) 2007-06-21
US9024039B2 (en) 2015-05-05
WO2007070494A3 (en) 2008-02-28
EP1968383A2 (de) 2008-09-17

Similar Documents

Publication Publication Date Title
ATE494280T1 (de) Stereoisomerisch angereicherte 3-aminocarbonyl- bicyclohepten-pyrimidindiamin-verbindungen und ihre verwendungen
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
GB0222495D0 (en) Compounds
MX2009006704A (es) Derivados de amina triciclicos como inhibidores de proteina de tirosina cinasa.
UA86063C2 (ru) Липосомы для снабжения лекарств
ECSP077296A (es) Fenilaminotiazoles sustituidos y su uso
UA83194C2 (ru) Производные пиримидина и их применение как модуляторов св2
ECSP077331A (es) Nuevos betamiméticos para el tratamiento de enfermedades de vías respiratorias
GEP20084452B (en) Sulfonamide derivatives for the treatment of diseases
EA201001143A1 (ru) Активаторы прокаспаз "исполнителей" 3, 6 и 7
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
CY1114952T1 (el) Ενεργοποιητες θειενο[2,3-b]πυριδινοδιονης της αμρκ και θεραπευτικες χρησεις αυτων
ECSP055964A (es) Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6
ATE494926T1 (de) Neuartige p2x7r-antagonisten und ihre verwendung
CY1108324T1 (el) Νεοι τεταρτοταγοποιημενοι εστερες κουινουκλιδινης
TW200611695A (en) Pyrrolopyridine derivatives
ECSP088745A (es) Derivados sustituidos de cromanol y su uso
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
TW200635597A (en) Substituted pteridines for the treatment of inflammatory diseases
UY29036A1 (es) Derivados de oxopiperidina, su preparacion y su aplicacion en terapeutica
ATE512968T1 (de) 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6- carboxamid und 2,3,4,5-tetrahydropyrrolo(1,2-a)- diazepin-7-carboxamid- derivate, ihre herstellung und therapeutische verwendung
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
TW200633711A (en) Substituted pteridines for the treatment of inflammatory diseases
SE0300457D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties